First estimates of the potential cost and cost saving of protecting childhood hearing from damage caused by congenital CMV infection

Williams, Eleri, Gray, Joanne, Luck, Suzanne, Atkinson, Claire, Embleton, Nicholas, Kadambari, Seilesh, Davis, Adrian, Griffiths, Paul, Sharland, Mike, Berrington, Janet and Clarke, Julie (2015) First estimates of the potential cost and cost saving of protecting childhood hearing from damage caused by congenital CMV infection. Archives of Disease in Childhood - Fetal and Neonatal Edition, 100 (6). E501-E506. ISSN 1359-2998

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1136/archdischild-2014-306756

Abstract

Background Congenital cytomegalovirus (cCMV) is an important cause of childhood deafness, which is modifiable if diagnosed within the first month of life. Targeted screening of infants who do not pass their newborn hearing screening tests in England is a feasible approach to identify and treat cases to improve hearing outcome.

Aims To conduct a cost analysis of targeted screening and subsequent treatment for cCMV-related sensorineural hearing loss (SNHL) in an, otherwise, asymptomatic infant, from the perspective of the UK National Health Service (NHS).

Methods Using data from the newborn hearing screening programme (NHSP) in England and a recent study of targeted screening for cCMV using salivary swabs within the NHSP, we estimate the cost (in UK pounds (£)) to the NHS. The cost of screening (time, swabs and PCR), assessing, treating and following up cases is calculated. The cost per case of preventing hearing deterioration secondary to cCMV with targeted screening is calculated.

Results The cost of identifying, assessing and treating a case of cCMV-related SNHL through targeted cCMV screening is estimated to be £6683. The cost of improving hearing outcome for an infant with cCMV-related SNHL through targeted screening and treatment is estimated at £14 202.

Conclusions The costs of targeted screening for cCMV using salivary swabs integrated within NHSP resulted in an estimate of cost per case that compares favourably with other screening programmes. This could be used in future studies to estimate the full economic value in terms of incremental costs and incremental health benefits.

Item Type: Article
Subjects: A100 Pre-clinical Medicine
Department: Faculties > Health and Life Sciences > School of Health, Community and Education Studies > Nursing, Midwifery and Health
Faculties > Health and Life Sciences > School of Health, Community and Education Studies > Public Health and Wellbeing
Depositing User: Nicola King
Date Deposited: 24 Nov 2015 11:36
Last Modified: 16 Nov 2016 14:52
URI: http://nrl.northumbria.ac.uk/id/eprint/24726

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics


Policies: NRL Policies | NRL University Deposit Policy | NRL Deposit Licence